May 1, 2024
Kaposi sarcoma discovery could facilitate drug development
Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma that will be key to the development of new drugs to treat the disease.
May 1, 2024
Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma that will be key to the development of new drugs to treat the disease.
January 23, 2024
The 13th annual UNC-Duke Viral Oncology and AIDS Malignancy Symposium featured talks and poster presentations on the latest research and insights in the field.
November 14, 2023
During University Research Week, the labs of Dirk Dittmer, PhD, and Jack Griffith, PhD, won the Art in Science Competition held by the UNC School of Medicine Office of Research.
February 14, 2023
What started as a shared passion for science grew into love for UNC Lineberger virologists Blossom Damania, PhD, and Dirk Dittmer, PhD, whose bond is continually strengthened through their commitment to research.
July 28, 2022
February 7, 2022
Blossom Damania, PhD, and Dirk Dittmer, PhD, are being recognized individually for their expertise in cancer virology and global oncology, and their service to the university and state.
January 31, 2022
June 7, 2021
Expertscape rated 12 UNC Lineberger faculty members as top-rated experts in their fields for its 2021 rankings.
November 5, 2020
August 25, 2020
A team of UNC researchers are partnering with colleagues at three institutions in Africa to study HIV-associated malignancies: Kaposi sarcoma, cervical cancer and lymphoma.